1. Academic Validation
  2. Effects of Gabapentinoids on Heroin-Induced Ventilatory Depression and Reversal by Naloxone

Effects of Gabapentinoids on Heroin-Induced Ventilatory Depression and Reversal by Naloxone

  • ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):519-525. doi: 10.1021/acsptsci.2c00230.
Shawn M Flynn 1 2 Charles P France 1 2 3
Affiliations

Affiliations

  • 1 Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 7764, San Antonio, Texas 78229, United States.
  • 2 Addiction Research, Treatment and Training (ARTT) Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, United States.
  • 3 Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, United States.
Abstract

Despite an increasing prevalence of gabapentinoids (gabapentin and pregabalin) in opioid overdose deaths, little research has evaluated potentially harmful interactions between gabapentinoids and opioids. This study sought to determine the effects of gabapentinoids on the ventilatory depressive effects of heroin and their reversal by naloxone. Rats were given gabapentin, pregabalin, or saline prior to receiving increasing doses of heroin while ventilation was monitored using whole-body plethysmography. In some sessions naloxone was administered following the largest dose of heroin. The primary outcomes of this study were minute volume and Pause. Heroin dose-dependently reduced minute volume and increased Pause. Administration of naloxone dose-dependently reversed the effects of heroin on ventilation. Gabapentinoids did not alter the ventilatory depressive effects of heroin alone but reduced the potency of naloxone to reverse heroin-induced ventilatory depression. These preliminary findings emphasize the need for further research evaluating interactions between gabapentinoids and opioids related to substance misuse and overdose.

Figures
Products